Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia
Open Access
- 2 January 2007
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 117 (1) , 165-174
- https://doi.org/10.1172/jci29415
Abstract
Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr–/–) and ARH (Arh–/–). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh–/– mice compared with Ldlr–/– mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh–/– mice than in Ldlr–/– mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh–/– mice (but not Ldlr–/– mice) internalized β-migrating VLDL (β-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.Keywords
This publication has 52 references indexed in Scilit:
- Normal Production Rate of Apolipoprotein B in LDL Receptor–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- The role of the LDL receptor in apolipoprotein B secretionJournal of Clinical Investigation, 2000
- Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemiaJournal of Clinical Investigation, 1999
- Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDLJournal of Clinical Investigation, 1999
- Characterization of a New Form of Inherited HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.Journal of Clinical Investigation, 1997
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Siblings with normal LDL receptor activity and severe hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100Atherosclerosis, 1992
- Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice.The Journal of cell biology, 1990